These data reveal a high prevalence (>35%) of MTAP deficiency in ductal adenocarcinoma of the pancreas and show that MTAP deficiency is mostly homogeneous across the entire cancer. This evidence concerns the gene MTAP and pancreatic ductal adenocarcinoma.